Hims & Hers Health Falls, On Holding Tumbles, Riot Platform Rises on Anthropic Deal
On this episode of Stock Movers:- Hims & Hers (HIMS) shares fall ahead of earnings. Hims & Hers Health Inc. plans to sell peptides, including sermorelin and glutathione, before the end of the year. The company is also awaiting a decision from the US Food and Drug Administration on whether to loosen restrictions on seven different compounds.- On Holdings (ONON) shares tumbled as much as 18% after the Swiss sneaker maker’s efforts to protect margin by maintaining full-price selling in a highly promotional environment hurt sales performance in the quarter. Management cut its annual topline…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.